Quick Takeaways
- Tricida, Inc. has 15 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 04 May 2025.
$0
Shares: 0
Insiders: 0
$0
Shares: 0
Insiders: 0
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Klaus R. Dr Veitinger | Director | Mixed | 15 Jun 2022 | |||
| Sandra I. Coufal | Director, 10%+ Owner | Mixed | 15 Jun 2022 | |||
| David Hirsch | Director | Mixed | 15 Jun 2022 | |||
| Mr. Geoffrey Parker | COO, CFO and EVP | Mixed | 28 Feb 2022 | |||
| David P. Bonita | Director, 10%+ Owner | Mixed | 22 Nov 2022 | |||
| Wilhelm Stahl | EVP, Chief Tech Officer | Mixed | 31 Dec 2021 | |||
| Kathryn E. Falberg | Director | Mixed | 15 Jun 2022 | |||
| Venrock Healthcare Capital Partners II, L.P. | 10%+ Owner | Mixed | 24 Oct 2022 | |||
| Robert J. Alpern | Director | Mixed | 23 Nov 2022 | |||
| ORBIMED ADVISORS LLC | Director, 10%+ Owner | Mixed | 22 Nov 2022 | |||
| Brian M. Isern | *possible member of 10% group, 10%+ Owner | Mixed | 11 Oct 2022 | |||
| Dawn Parsell Otto | EVP, Clinical Development | Mixed | 28 Feb 2022 | |||
| Robert McKague | EVP, General Counsel | Mixed | 28 Feb 2022 | |||
| Annie Yoshiyama | Senior VP, Finance and CAO | Mixed | 05 Aug 2022 | |||
| Gerrit Klaerner | President and CEO, Director | Mixed | 28 Feb 2022 |
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Brian M. Isern |
3/4/5
|
*possible member of 10% group, 10%+ Owner |
—
class O/S missing
|
5,563,493
|
— | — | 11 Oct 2022 | |
| Venrock Healthcare Capital Partners II, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,751,406
|
— | — | 24 Oct 2022 | |
| Gerrit Klaerner |
3/4/5
|
President and CEO, Director |
—
class O/S missing
|
511,000
|
— | — | 28 Feb 2022 | |
| Dawn Parsell Otto |
3/4/5
|
EVP, Clinical Development |
—
class O/S missing
|
256,000
|
— | — | 28 Feb 2022 | |
| Mr. Geoffrey Parker |
3/4/5
|
COO, CFO and EVP |
—
class O/S missing
|
256,000
|
— | — | 28 Feb 2022 | |
| Robert McKague |
3/4/5
|
EVP, General Counsel |
—
class O/S missing
|
256,000
|
— | — | 28 Feb 2022 | |
| David Hirsch |
3/4/5
|
Director |
—
class O/S missing
|
27,207
|
— | — | 15 Jun 2022 | |
| Kathryn E. Falberg |
3/4/5
|
Director |
—
class O/S missing
|
27,207
|
— | — | 15 Jun 2022 | |
| Klaus R. Dr Veitinger |
3/4/5
|
Director |
—
class O/S missing
|
27,207
|
— | — | 15 Jun 2022 | |
| Sandra I. Coufal |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
27,207
|
— | — | 15 Jun 2022 | |
| Wilhelm Stahl |
3/4/5
|
EVP, Chief Tech Officer |
—
class O/S missing
|
21,682
|
— | — | 31 Dec 2021 | |
| Annie Yoshiyama |
3/4/5
|
Senior VP, Finance and CAO |
—
class O/S missing
|
14,000
|
— | — | 05 Aug 2022 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||